US6313096B1
(en)
|
1988-04-28 |
2001-11-06 |
Trigen Limited |
Inhibitors of trypsin-like enzymes
|
US5574014A
(en)
*
|
1988-04-28 |
1996-11-12 |
Thrombosis Research Institute |
Inhibitors of trypsin-like enzymes
|
US6825169B1
(en)
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
MX9206628A
(es)
*
|
1991-11-22 |
1993-05-01 |
Boehringer Ingelheim Pharma |
Ester de prolinaboronato y metodo para su preparacion.
|
CA2133657A1
(en)
*
|
1992-04-16 |
1993-10-28 |
Peter R. Bernstein |
Substituted derivatives
|
FR2701951B1
(fr)
*
|
1993-02-24 |
1995-06-09 |
Adir |
Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
IL108797A0
(en)
*
|
1993-03-03 |
1994-06-24 |
Sandoz Ag |
Amino acid derivatives, their preparation and pharmaceutical compositions containing them
|
US5563127A
(en)
*
|
1993-03-24 |
1996-10-08 |
The Dupont Merck Pharmaceutical Company |
Boronic acid and ester inhibitors of thrombin
|
AU6448794A
(en)
*
|
1993-03-24 |
1994-10-11 |
Du Pont Merck Pharmaceutical Company, The |
Boronic acid and ester inhibitors of thrombin
|
US5783563A
(en)
*
|
1993-06-03 |
1998-07-21 |
Astra Aktiebolag |
Method for treatment or prophylaxis of venous thrombosis
|
US6984627B1
(en)
|
1993-06-03 |
2006-01-10 |
Astrazeneca Ab |
Peptide derivatives
|
SE9301916D0
(sv)
*
|
1993-06-03 |
1993-06-03 |
Ab Astra |
New peptides derivatives
|
IL111176A0
(en)
*
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
|
IL111175A0
(en)
*
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
|
US5462964A
(en)
*
|
1993-10-20 |
1995-10-31 |
The Du Pont Merck Pharmaceutical Company |
Dipeptide boronic acid inhibitors of trypsin-like enzymes
|
CA2174311A1
(en)
*
|
1993-10-07 |
1995-04-13 |
Gregory James Pacofsky |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
US6060462A
(en)
*
|
1993-10-20 |
2000-05-09 |
Dupont Pharmaceuticals Company |
Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
|
GB9401483D0
(en)
*
|
1994-01-26 |
1994-03-23 |
Sandoz Ltd |
Organic compounds
|
US5693617A
(en)
*
|
1994-03-15 |
1997-12-02 |
Proscript, Inc. |
Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
|
DE4421052A1
(de)
|
1994-06-17 |
1995-12-21 |
Basf Ag |
Neue Thrombininhibitoren, ihre Herstellung und Verwendung
|
FR2721611B1
(fr)
*
|
1994-06-22 |
1996-09-27 |
Adir |
Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent .
|
US5510369A
(en)
*
|
1994-07-22 |
1996-04-23 |
Merck & Co., Inc. |
Pyrrolidine thrombin inhibitors
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
SE9404196D0
(sv)
*
|
1994-12-02 |
1994-12-02 |
Astra Ab |
New antithrombotic formulation
|
WO1996025426A1
(de)
*
|
1995-02-17 |
1996-08-22 |
Basf Aktiengesellschaft |
Neue dipeptidische amidine als thrombin-inhibitoren
|
US5629324A
(en)
*
|
1995-04-10 |
1997-05-13 |
Merck & Co., Inc. |
Thrombin inhibitors
|
CA2227607C
(en)
|
1995-07-26 |
2008-06-10 |
Mitsubishi Chemical Corporation |
Penicillaminamide derivatives
|
GB9515489D0
(en)
*
|
1995-07-28 |
1995-09-27 |
Sandoz Ltd |
Organic compounds
|
TW541316B
(en)
|
1995-12-21 |
2003-07-11 |
Astrazeneca Ab |
Prodrugs of thrombin inhibitors
|
FR2745288B1
(fr)
*
|
1996-02-27 |
1998-04-17 |
Adir |
Nouveaux derives de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US5965532A
(en)
*
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
US6004955A
(en)
*
|
1996-08-15 |
1999-12-21 |
Dupont Pharmaceuticals Company |
Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists
|
US6063794A
(en)
*
|
1996-10-11 |
2000-05-16 |
Cor Therapeutics Inc. |
Selective factor Xa inhibitors
|
EP0932615A1
(en)
*
|
1996-10-11 |
1999-08-04 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
US6262047B1
(en)
|
1996-10-11 |
2001-07-17 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6369080B2
(en)
|
1996-10-11 |
2002-04-09 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
AU743544B2
(en)
*
|
1996-10-11 |
2002-01-31 |
Millennium Pharmaceuticals, Inc. |
Selective factor Xa inhibitors
|
US6194435B1
(en)
|
1996-10-11 |
2001-02-27 |
Cor Therapeutics, Inc. |
Lactams as selective factor Xa inhibitors
|
WO1998016524A1
(en)
*
|
1996-10-11 |
1998-04-23 |
Cor Therapeutics, Inc. |
HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS
|
US5798377A
(en)
*
|
1996-10-21 |
1998-08-25 |
Merck & Co., Inc. |
Thrombin inhibitors
|
EP0975659A1
(en)
*
|
1997-04-14 |
2000-02-02 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
US6204268B1
(en)
|
1997-04-14 |
2001-03-20 |
Cor Therapeutics, Inc |
Selective factor Xa inhibitors
|
EP0977773A1
(en)
|
1997-04-14 |
2000-02-09 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
EP0975625A1
(en)
|
1997-04-14 |
2000-02-02 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
US6040145A
(en)
|
1997-05-07 |
2000-03-21 |
Tufts University |
Potentiation of the immune response
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
EA200000048A1
(ru)
|
1997-06-19 |
2000-08-28 |
Дюпон Фармасьютикалз Компани |
ИНГИБИТОРЫ ФАКТОРА Ха, СОДЕРЖАЩИЕ ГРУППУ С НЕЙТРАЛЬНОЙ P1-СПЕЦИФИЧНОСТЬЮ
|
US6333321B1
(en)
|
1997-08-11 |
2001-12-25 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6228854B1
(en)
|
1997-08-11 |
2001-05-08 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6218382B1
(en)
|
1997-08-11 |
2001-04-17 |
Cor Therapeutics, Inc |
Selective factor Xa inhibitors
|
CN1163594C
(zh)
|
1997-09-29 |
2004-08-25 |
尖端医疗有限公司 |
体外造血细胞的刺激
|
BR9907112A
(pt)
|
1998-01-26 |
2000-10-24 |
Basf Ag |
Composto, medicamento, e, uso de um composto
|
WO1999050249A2
(en)
|
1998-04-01 |
1999-10-07 |
Du Pont Pharmaceuticals Company |
Pyrimidines and triazines as integrin antagonists
|
TWI252107B
(en)
|
1998-05-04 |
2006-04-01 |
Piint Therapeutics Inc |
Pharmaceutical compositions and kits for hematopoietic usage
|
ATE231512T1
(de)
|
1998-06-05 |
2003-02-15 |
Point Therapeutics Inc |
Cyclische boroprolinverbindungen
|
AU3127900A
(en)
|
1998-12-23 |
2000-07-31 |
Du Pont Pharmaceuticals Company |
Thrombin or factor xa inhibitors
|
US6890904B1
(en)
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
AU2002230764A1
(en)
*
|
2000-12-13 |
2002-06-24 |
Bristol-Myers Squibb Pharma Company |
Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
|
US6528503B2
(en)
|
2000-12-18 |
2003-03-04 |
Merck & Co., Inc. |
Thrombin inhibitors
|
WO2002050056A1
(en)
|
2000-12-18 |
2002-06-27 |
Merck & Co., Inc. |
Benzylamine derivatives and their use as thrombin inhibitors
|
WO2002064559A2
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
Thrombin inhibitors
|
EP1399468B1
(en)
|
2001-05-30 |
2006-02-15 |
Novartis AG |
2-((n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl)-amino)-alkylboronic acid derivatives
|
US7084134B2
(en)
|
2002-05-02 |
2006-08-01 |
Merk & Co., Inc. |
Thrombin inhibitors
|
DE60317039T2
(de)
|
2002-09-09 |
2008-07-31 |
Trigen Ltd. |
Peptidborsäuren und deren Verwendung in der Herstellung von Salzen derselben
|
US20050288253A1
(en)
|
2002-09-09 |
2005-12-29 |
Trigen Limited |
Boronic acid salts
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
HUE064412T2
(hu)
|
2016-06-21 |
2024-03-28 |
Orion Ophthalmology LLC |
Heterociklusos prolinamid-származékok
|
JP7164521B2
(ja)
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|